These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 37165159)

  • 21. High Preoperative Platelet to Lymphocyte Ratio Is Associated with a Greater Risk of Postoperative Complications and Hematogenous Recurrences in Esophageal Squamous Cell Carcinoma Patients Receiving Neoadjuvant Treatment.
    Sasahara M; Kanda M; Shimizu D; Takami H; Inokawa Y; Hattori N; Hayashi M; Tanaka C; Fujiwara M; Nakayama G; Kodera Y
    Dig Surg; 2023; 40(1-2):48-57. PubMed ID: 36893749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Minimally invasive esophagectomy attenuates the postoperative inflammatory response and improves survival compared with open esophagectomy in patients with esophageal cancer: a propensity score matched analysis.
    Yamashita K; Watanabe M; Mine S; Toihata T; Fukudome I; Okamura A; Yuda M; Hayami M; Ishizuka N; Imamura Y
    Surg Endosc; 2018 Nov; 32(11):4443-4450. PubMed ID: 29644466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Novel Prognostic Scoring System Using Inflammatory Response Biomarkers for Esophageal Squamous Cell Carcinoma.
    Hirahara N; Tajima Y; Fujii Y; Yamamoto T; Hyakudomi R; Hirayama T; Taniura T; Ishitobi K; Kidani A; Kawabata Y
    World J Surg; 2018 Jan; 42(1):172-184. PubMed ID: 28744596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Combination of Preoperative Nutritional Risk Screening-2002 and Neutrophil-to-Lymphocyte Ratio is a Useful Prognostic Marker in Patients with Esophageal Squamous Cell Carcinoma.
    Guo XW; Zhou JY; Jiang W; Ji L; Liu YC; Yin XX
    Nutr Cancer; 2021; 73(4):588-595. PubMed ID: 32434418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated preoperative neutrophil-to-lymphocytes ratio predicts poor prognosis after esophagectomy in T1 esophageal cancer.
    Nakamura K; Yoshida N; Baba Y; Kosumi K; Uchihara T; Kiyozumi Y; Ohuchi M; Ishimoto T; Iwatsuki M; Sakamoto Y; Watanabe M; Baba H
    Int J Clin Oncol; 2017 Jun; 22(3):469-475. PubMed ID: 28097441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does robot-assisted minimally invasive esophagectomy really have the advantage of lymphadenectomy over video-assisted minimally invasive esophagectomy in treating esophageal squamous cell carcinoma? A propensity score-matched analysis based on short-term outcomes.
    Deng HY; Luo J; Li SX; Li G; Alai G; Wang Y; Liu LX; Lin YD
    Dis Esophagus; 2019 Jul; 32(7):. PubMed ID: 30496378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prophylactic thoracic duct ligation is associated with poor prognosis and regional lymph node relapse in esophageal squamous cell carcinoma.
    Chen JY; Liu QW; Zhang SS; Li JB; Yang H; Wen J; Fu JH
    J Surg Oncol; 2020 Aug; 122(2):336-343. PubMed ID: 32410255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postoperative survival effect of the number of examined lymph nodes on esophageal squamous cell carcinoma with pathological stage T1-3N0M0.
    Wu LL; Zhong JD; Zhu JL; Kang L; Huang YY; Lin P; Long H; Zhang LJ; Ma QL; Qiu LH; Ma GW
    BMC Cancer; 2022 Jan; 22(1):118. PubMed ID: 35090428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of inflammation-based prognostic score on survival after curative thoracoscopic esophagectomy for esophageal cancer.
    Hirahara N; Matsubara T; Hayashi H; Takai K; Fujii Y; Tajima Y
    Eur J Surg Oncol; 2015 Oct; 41(10):1308-15. PubMed ID: 26235238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of short- and long-term outcomes between 3-field and modern 2-field lymph node dissections for thoracic oesophageal squamous cell carcinoma: a propensity score matching analysis.
    Fan N; Yang H; Zheng J; Chen D; Wang W; Tan Z; Huang Y; Lin P
    Interact Cardiovasc Thorac Surg; 2019 Sep; 29(3):434-441. PubMed ID: 31135037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endoscopic Submucosal Dissection Versus Surgery for Superficial Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Survival Analysis.
    Lee HD; Chung H; Kwak Y; Choi J; Lee A; Kim JL; Cho SJ; Kim SG
    Clin Transl Gastroenterol; 2020 Jul; 11(7):e00193. PubMed ID: 32675704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutrophil-to-lymphocyte ratio as an independent predictor for survival in patients with localized clear cell renal cell carcinoma after radiofrequency ablation: a propensity score matching analysis.
    Chang X; Zhang F; Liu T; Wang W; Guo H
    Int Urol Nephrol; 2017 Jun; 49(6):967-974. PubMed ID: 28247169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing survival between neoadjuvant chemoradiotherapy followed by open or thoracoscopic oesophagectomy in patients with oesophageal squamous cell carcinoma.
    Chen HS; Lin CH; Wu SC; Wang BY
    Eur J Cardiothorac Surg; 2022 Jul; 62(2):. PubMed ID: 35303068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer.
    Sharaiha RZ; Halazun KJ; Mirza F; Port JL; Lee PC; Neugut AI; Altorki NK; Abrams JA
    Ann Surg Oncol; 2011 Nov; 18(12):3362-9. PubMed ID: 21547702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Propensity-Matched Analysis Comparing Survival After Hybrid Thoracoscopic-Laparotomy Esophagectomy and Complete Thoracoscopic-Laparoscopic Esophagectomy.
    Li KK; Wang YJ; Liu XH; Wang RW; Jiang YG; Guo W
    World J Surg; 2019 Mar; 43(3):853-861. PubMed ID: 30386913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short- and mid-term outcomes of robotic versus thoraco-laparoscopic McKeown esophagectomy for squamous cell esophageal cancer: a propensity score-matched study.
    Yang Y; Zhang X; Li B; Hua R; Yang Y; He Y; Ye B; Guo X; Sun Y; Li Z
    Dis Esophagus; 2020 Jun; 33(6):. PubMed ID: 31608939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Propensity score analysis comparing survival between definitive chemoradiotherapy and esophagectomy with adjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma.
    Chang YL; Cheng YF; Chen HS; Wu SC; Hung WH; Chen HC; Huang CL; Cheng CY; Wang BY
    PLoS One; 2022; 17(10):e0271338. PubMed ID: 36227954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thoracic Duct Resection During Esophagectomy Does Not Contribute to Improved Prognosis in Esophageal Squamous Cell Carcinoma: A Propensity Score Matched-Cohort Study.
    Oshikiri T; Takiguchi G; Miura S; Goto H; Otsubo D; Hasegawa H; Yamamoto M; Kanaji S; Yamashita K; Matsuda T; Fujino Y; Tominaga M; Nakamura T; Suzuki S; Kakeji Y
    Ann Surg Oncol; 2019 Nov; 26(12):4053-4061. PubMed ID: 31313045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NOX4 overexpression is a poor prognostic factor in patients undergoing curative esophagectomy for esophageal squamous cell carcinoma.
    Chen YH; Lu HI; Lo CM; Hsiao CC; Li SH
    Surgery; 2020 Mar; 167(3):620-627. PubMed ID: 31889545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcervical inflatable mediastinoscopic esophagectomy versus thoracoscopic esophagectomy for local early- and intermediate-stage esophageal squamous cell carcinoma: A propensity score-matched analysis.
    Chen Z; Huang K; Wei R; Liu C; Fang Y; Wu B; Xu Z; Ding X; Tang H
    J Surg Oncol; 2022 Apr; 125(5):839-846. PubMed ID: 35066884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.